Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2631
Nomenclature: ribonucleotide reductase regulatory subunit M2
Abbreviated Name: ribonucleotide reductase M2
Family: Nucleoside synthesis and metabolism, 1.17.4.1 Ribonucleoside-diphosphate reductases
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 389 | 2p25.1 | RRM2 | ribonucleotide reductase regulatory subunit M2 | |
Mouse | - | 390 | 12 8.5 cM | Rrm2 | ribonucleotide reductase M2 | |
Rat | - | 390 | 6q16 | Rrm2 | ribonucleotide reductase regulatory subunit M2 |
Previous and Unofficial Names |
ribonucleoside-diphosphate reductase subunit | Rrm2 | ribonucleotide reductase M2 |
Database Links | |
Alphafold | P31350 (Hs), P11157 (Mm), Q4KLN6 (Rn) |
BRENDA | 1.17.4.1 |
ChEMBL Target | CHEMBL1954 (Hs), CHEMBL3527 (Mm) |
DrugBank Target | P31350 (Hs) |
Ensembl Gene | ENSG00000171848 (Hs), ENSMUSG00000020649 (Mm), ENSRNOG00000054286 (Rn) |
Entrez Gene | 6241 (Hs), 20135 (Mm), 362720 (Rn) |
Human Protein Atlas | ENSG00000171848 (Hs) |
KEGG Enzyme | 1.17.4.1 |
KEGG Gene | hsa:6241 (Hs), mmu:20135 (Mm), rno:362720 (Rn) |
OMIM | 180390 (Hs) |
Pharos | P31350 (Hs) |
RefSeq Nucleotide | NM_001165931 (Hs), NM_009104 (Mm), NM_001025740 (Rn) |
RefSeq Protein | NP_001159403 (Hs), NP_033130 (Mm), NP_001020911 (Rn) |
UniProtKB | P31350 (Hs), P11157 (Mm), Q4KLN6 (Rn) |
Wikipedia | RRM2 (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inhibitor Comments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Please see the Inhibitors table on the More detailed page for RRM1, for information on approved drugs which may act via this protein. |
1. Heinemann V, Xu YZ, Chubb S, Sen A, Hertel LW, Grindey GB, Plunkett W. (1990) Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. Mol Pharmacol, 38 (4): 567-72. [PMID:2233693]
2. Parker WB, Shaddix SC, Chang CH, White EL, Rose LM, Brockman RW, Shortnacy AT, Montgomery JA, Secrist 3rd JA, Bennett Jr LL. (1991) Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate. Cancer Res, 51 (9): 2386-94. [PMID:1707752]
3. Shao J, Zhou B, Zhu L, Bilio AJ, Su L, Yuan YC, Ren S, Lien EJ, Shih J, Yen Y. (2005) Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay. Biochem Pharmacol, 69 (4): 627-34. [PMID:15670581]
4. Tseng WC, Derse D, Cheng YC, Brockman RW, Bennett Jr LL. (1982) In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Mol Pharmacol, 21 (2): 474-7. [PMID:7048062]
Nucleoside synthesis and metabolism: ribonucleotide reductase regulatory subunit M2. Last modified on 28/11/2018. Accessed on 09/09/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2631.